neostigmine has been researched along with Diffuse Myofascial Pain Syndrome in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
KABAT, H | 1 |
JONES, CW | 1 |
Voiculescu, V | 1 |
Călcăianu, G | 1 |
Stănescu, A | 1 |
2 other studies available for neostigmine and Diffuse Myofascial Pain Syndrome
Article | Year |
---|---|
Studies on neuromuscular dysfunction; neostigmine therapy of acute and chronic cervical intramuscular fibrositis.
Topics: Disease; Fibromyalgia; Humans; Injections, Intramuscular; Neck; Neostigmine; Rheumatic Diseases | 1945 |
Abnormal reflexes in the "stiff-man" syndrome.
Topics: Adrenocorticotropic Hormone; Chloral Hydrate; Chlorpromazine; Cortisone; Electromyography; Female; F | 1970 |